Selbo P K, Sivam G, Fodstad O, Sandvig K, Berg K
Department of Biophysics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
Int J Cancer. 2000 Sep 15;87(6):853-9. doi: 10.1002/1097-0215(20000915)87:6<853::aid-ijc15>3.0.co;2-0.
Photochemical internalisation (PCI) was recently demonstrated as a unique procedure for site-specific delivery of several types of membrane impermeable macromolecules from endocytotic vesicles to the cytosol (Berg et al., 1999). The technology is based on the cytosolic release of endocytosed macromolecules from endosomes and lysosomes upon exposure of cells to photosensitising compounds, which became localised to these vesicles, and light. In our study the possibility to increase the cytotoxic effect of the immunotoxin MOC31-gelonin by PCI was examined. The type I ribosome-inactivating protein gelonin was covalently linked to the monoclonal IgG1 antibody MOC31, directed against epithelial glycoprotein-2 (EGP-2), an antigen expressed on most carcinoma cells. Five different cell lines, of which 4 expressed EGP-2, were treated with MOC31-gelonin and endosomal and lysosomal localising photosensitisers, followed by exposure to light. Insignificant cytotoxicity of the MOC31-gelonin was observed when the cells were incubated with the immunotoxin alone. However, in combination with endosomal and lysosomal localising photosensitizers, we demonstrate synergistic toxic effect of the MOC31-gelonin conjugate in a light-dependent manner. Our results indicate that PCI is a promising tool for increasing the cytotoxicity of immunotoxins, which is important for further improvement of the PCI concept towards possible use in cancer therapy.
光化学内化(PCI)最近被证明是一种将几种类型的膜不可渗透大分子从内吞小泡位点特异性递送至细胞质的独特方法(Berg等人,1999年)。该技术基于细胞暴露于光敏化合物后,内吞的大分子从内体和溶酶体中释放到细胞质中,这些光敏化合物定位于这些小泡,并在光照下发挥作用。在我们的研究中,研究了通过PCI增强免疫毒素MOC31-凝胶毒素细胞毒性作用的可能性。I型核糖体失活蛋白凝胶毒素与单克隆IgG1抗体MOC31共价连接,MOC31针对上皮糖蛋白-2(EGP-2),这是一种在大多数癌细胞上表达的抗原。用MOC31-凝胶毒素和定位于内体和溶酶体的光敏剂处理五种不同的细胞系,其中4种表达EGP-2,然后进行光照。当细胞单独与免疫毒素孵育时,未观察到MOC31-凝胶毒素有明显的细胞毒性。然而与定位于内体和溶酶体的光敏剂联合使用时,我们证明了MOC31-凝胶毒素缀合物以光依赖的方式具有协同毒性作用。我们的结果表明,PCI是增强免疫毒素细胞毒性的一种有前景的工具,这对于进一步改进PCI概念以可能用于癌症治疗非常重要。